Congress of Clinical Rheumatology Annual Meeting

Congress of Clinical Rheumatology Annual Meeting

Source:

Healio Interviews

Disclosures: Calabrese reports consulting relationships with AbbVie, Centecor Biopharmaceutical, Crescendo Bioscience, GlaxoSmithKline, Horizon Pharma, Janssen Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals and UCB.
May 12, 2022
1 min watch
Save

VIDEO: Immunocompromised care in COVID-19 to challenge physicians ‘for rest of our lives’

Source:

Healio Interviews

Disclosures: Calabrese reports consulting relationships with AbbVie, Centecor Biopharmaceutical, Crescendo Bioscience, GlaxoSmithKline, Horizon Pharma, Janssen Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals and UCB.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

DESTIN, Fla. — All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to Leonard H. Calabrese, DO, at the Congress of Clinical Rheumatology East.

These patients also require access to home testing, as many of the available COVID-19 therapies, including antivirals and monoclonal antibodies, are “time limited” and will be ineffective if administered several weeks after infection, he added.

“We’re rheumatologists — this is the type of patient we take care of,” said Calabrese, who is chief medical editor of Healio Rheumatology, a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and RJ Fasenmyer chair of clinical immunology at the Cleveland Clinic. “This will be a challenge that is prevalent with us for the rest of our lives, because COVID-19, SARS-CoV-2 infection, is unlikely to leave the planet.”